Accessing a high liver dome lesion close to the heart

The patient was diagnosed with colorectal cancer in 2021 and a partial colon resection was performed. Months later, they returned via the multidisciplinary tumor board with a CRLM very close to the heart. Surgery was considered, but in the end, due to the presence of CAS-One IR, the patient was referred for ablation at the end of 2022. CAS-One IR made this challenging case straightforward with a single probe approach, and the one-month follow-up shows a complete ablation and no recurrence.

 

 

Needle verification image in MPR showing actual ablation zone in respect to needle position

Ablation assessment in MPR showing the margins and the quantitative margin assessment tool;  Ablasure  

Ablation zone visible on CE-CT scan after one-month follow-up 

Name: Dr. Simon Smith 

Institution: Ipswich Hospital - East Suffolk and North Essex NHS Foundation Trust

Patient age and sex:  81 year old male

Initial condition:

• Patient was diagnosed with T3N1 colon cancer in 2021 
• And was treated with a right hemicolectomy
• Follow-up in 2022 revealed a solitary liver metastasis in segment IV/VIII 
• Surgery was considered, but the MDT advised for a percutaneous ablation with CAS-One IR 

Treatment: 

• The location of the lesion was not able to be reached with ultrasound 
• Considering the proximity to the heart, CAS-One IR was chosen for its highly accurate targeting
• A single trajectory of about 15 cm was planned and achieved in the first attempt
• An ablation at 150W for 4.5 minutes with the Medtronic Emprint needle was completed
• AblaSure, quantitative margin assessment was used to confirm adequate margins

Result:

• Discharged after one day without any complications 
• Patient had a one-month CE-CT follow-up (as seen on the image above) with total tumor response after ablation 
• This difficult trajectory was safely planned and placed using CAS-One IR navigation capabilities, avoiding needle advancement through the lung and with a safe distance to the heart 
• Quality Ablation allows complete tumor responds in lesions located in any liver segment, regardless of proximity to main vascular, subphrenic, or subcapsular localization